373 related articles for article (PubMed ID: 10381772)
1. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
2. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
4. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
5. GV196771A, an NMDA receptor/glycine site antagonist, attenuates mechanical allodynia in neuropathic rats and reduces tolerance induced by morphine in mice.
Quartaroli M; Fasdelli N; Bettelini L; Maraia G; Corsi M
Eur J Pharmacol; 2001 Nov; 430(2-3):219-27. PubMed ID: 11711034
[TBL] [Abstract][Full Text] [Related]
6. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
7. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
8. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
10. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist.
Chen HS; Chen J
Eur J Pain; 2000; 4(4):389-401. PubMed ID: 11124011
[TBL] [Abstract][Full Text] [Related]
11. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
12. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
Nishiyama T
Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
[TBL] [Abstract][Full Text] [Related]
13. Hyperalgesia and neural excitability following injuries to central and peripheral branches of axons and somata of dorsal root ganglion neurons.
Song XJ; Vizcarra C; Xu DS; Rupert RL; Wong ZN
J Neurophysiol; 2003 Apr; 89(4):2185-93. PubMed ID: 12612043
[TBL] [Abstract][Full Text] [Related]
14. Dantrolene antagonizes the glycineB site of the NMDA receptor.
Salinska E; Sobczuk A; Lazarewicz JW
Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist.
Taniguchi K; Shinjo K; Mizutani M; Shimada K; Ishikawa T; Menniti FS; Nagahisa A
Br J Pharmacol; 1997 Nov; 122(5):809-12. PubMed ID: 9384494
[TBL] [Abstract][Full Text] [Related]
16. Depletion of capsaicin-sensitive afferents prevents lamina-dependent increases in spinal N-methyl-D-aspartate receptor subunit 1 expression and phosphorylation associated with thermal hyperalgesia in neuropathic rats.
Roh DH; Kim HW; Yoon SY; Seo HS; Kwon YB; Han HJ; Beitz AJ; Lee JH
Eur J Pain; 2008 Jul; 12(5):552-63. PubMed ID: 17933570
[TBL] [Abstract][Full Text] [Related]
17. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
18. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
Banks P; Franks NP; Dickinson R
Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
[TBL] [Abstract][Full Text] [Related]
19. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus.
Bordi F; Quartaroli M
Pain; 2000 Feb; 84(2-3):213-24. PubMed ID: 10666526
[TBL] [Abstract][Full Text] [Related]
20. Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
Christoph T; Reissmüller E; Schiene K; Englberger W; Chizh BA
Brain Res; 2005 Jun; 1048(1-2):218-27. PubMed ID: 15922311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
